Connection

Jean-Charles Soria to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Receptor, ErbB-2.
Jean-Charles Soria
Connection Strength
0.700
Receptor, ErbB-2
  1. Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors. J Clin Oncol. 2014 Jan 10; 32(2):68-75.
    View in: PubMed
    Score: 0.470
  2. Phase I open-label study of afatinib plus vinorelbine in patients with solid tumours overexpressing EGFR and/or HER2. Br J Cancer. 2018 02 06; 118(3):344-352.
    View in: PubMed
    Score: 0.156
  3. Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica. Tumori. 2018 Dec; 104(6):NP38-NP41.
    View in: PubMed
    Score: 0.040
  4. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet. 2016 Apr 02; 387(10026):1415-1426.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.